DEREK KLEMM: Open Payments
NPI 1225300494 · DEMOREST, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 67 payments from 21 companies in 2025. Trend: 2023 $1,034 · 2024 $1,098 · 2025 $1,258
Food & beverage: $1,258
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $165 |
| ABBVIE INC. | 13 | $162 |
| Braeburn Inc. | 5 | $123 |
| Corcept Therapeutics | 5 | $112 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Lilly USA, LLC | 4 | $66 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Exact Sciences Corporation | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
Products named: FANAPT, BRIXADI, Korlym, VRAYLAR, GVOKE HYPOPEN, MOUNJARO, Cologuard Collection Kit, REXULTI.
Industry payments across GA — which companies pay providers there.
